FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147010930> ?p ?o ?g. }

• W2147010930 abstract "Radiotherapy (RT) and androgen-deprivation therapy (ADT) are standard treatments for advanced prostate cancer (PC). Tumor vascularization is recognized as an important physiological feature likely to impact on both RT and ADT response, and this study therefore aimed to characterize the vascular responses to RT and ADT in experimental PC. Using mice implanted with CWR22 PC xenografts, vascular responses to RT and ADT by castration were visualized in vivo by DCE MRI, before contrast-enhancement curves were analyzed both semi-quantitatively and by pharmacokinetic modeling. Extracted image parameters were correlated to the results from ex vivo quantitative fluorescent immunohistochemical analysis (qIHC) of tumor vascularization (9 F1), perfusion (Hoechst 33342), and hypoxia (pimonidazole), performed on tissue sections made from tumors excised directly after DCE MRI. Compared to untreated (Ctrl) tumors, an improved and highly functional vascularization was detected in androgen-deprived (AD) tumors, reflected by increases in DCE MRI parameters and by increased number of vessels (VN), vessel density ( VD), and vessel area fraction ( VF) from qIHC. Although total hypoxic fractions ( HF) did not change, estimated acute hypoxia scores ( AHS) – the proportion of hypoxia staining within 50 μm from perfusion staining – were increased in AD tumors compared to in Ctrl tumors. Five to six months after ADT renewed castration-resistant (CR) tumor growth appeared with an even further enhanced tumor vascularization. Compared to the large vascular changes induced by ADT, RT induced minor vascular changes. Correlating DCE MRI and qIHC parameters unveiled the semi-quantitative parameters area under curve ( AUC) from initial time-points to strongly correlate with VD and VF, whereas estimation of vessel size ( VS) by DCE MRI required pharmacokinetic modeling. HF was not correlated to any DCE MRI parameter, however, AHS may be estimated after pharmacokinetic modeling. Interestingly, such modeling also detected tumor necrosis very strongly. DCE MRI reliably allows non-invasive assessment of tumors’ vascular function. The findings of increased tumor vascularization after ADT encourage further studies into whether these changes are beneficial for combined RT, or if treatment with anti-angiogenic therapy may be a strategy to improve the therapeutic efficacy of ADT in advanced PC." @default.
• W2147010930 created "2016-06-24" @default.
• W2147010930 creator A5000225935 @default.
• W2147010930 creator A5007316380 @default.
• W2147010930 creator A5023112999 @default.
• W2147010930 creator A5034483419 @default.
• W2147010930 creator A5040190048 @default.
• W2147010930 creator A5051572998 @default.
• W2147010930 creator A5053482931 @default.
• W2147010930 creator A5064042438 @default.
• W2147010930 date "2012-05-23" @default.
• W2147010930 modified "2023-10-16" @default.
• W2147010930 title "Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer" @default.
• W2147010930 cites W1485692275 @default.
• W2147010930 cites W1964660524 @default.
• W2147010930 cites W1968608224 @default.
• W2147010930 cites W1984935646 @default.
• W2147010930 cites W2007287727 @default.
• W2147010930 cites W2011810742 @default.
• W2147010930 cites W2012276721 @default.
• W2147010930 cites W2014852128 @default.
• W2147010930 cites W2017709634 @default.
• W2147010930 cites W2024903578 @default.
• W2147010930 cites W2035104343 @default.
• W2147010930 cites W2038145387 @default.
• W2147010930 cites W2042098439 @default.
• W2147010930 cites W2046905207 @default.
• W2147010930 cites W2054254499 @default.
• W2147010930 cites W2066747909 @default.
• W2147010930 cites W2070428637 @default.
• W2147010930 cites W2088504180 @default.
• W2147010930 cites W2095893831 @default.
• W2147010930 cites W2112957932 @default.
• W2147010930 cites W2117511763 @default.
• W2147010930 cites W2125785593 @default.
• W2147010930 cites W2126785034 @default.
• W2147010930 cites W2128770434 @default.
• W2147010930 cites W2140675573 @default.
• W2147010930 cites W2141876821 @default.
• W2147010930 cites W2148739751 @default.
• W2147010930 cites W2157000380 @default.
• W2147010930 cites W2157169414 @default.
• W2147010930 cites W2159328080 @default.
• W2147010930 cites W2165836181 @default.
• W2147010930 cites W2166172448 @default.
• W2147010930 cites W2166554521 @default.
• W2147010930 cites W2166725011 @default.
• W2147010930 cites W2167693206 @default.
• W2147010930 cites W4236621639 @default.
• W2147010930 doi "https://doi.org/10.1186/1748-717x-7-75" @default.
• W2147010930 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3441216" @default.
• W2147010930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22621752" @default.
• W2147010930 hasPublicationYear "2012" @default.
• W2147010930 type Work @default.
• W2147010930 sameAs 2147010930 @default.
• W2147010930 citedByCount "23" @default.
• W2147010930 countsByYear W21470109302013 @default.
• W2147010930 countsByYear W21470109302014 @default.
• W2147010930 countsByYear W21470109302015 @default.
• W2147010930 countsByYear W21470109302016 @default.
• W2147010930 countsByYear W21470109302017 @default.
• W2147010930 countsByYear W21470109302018 @default.
• W2147010930 countsByYear W21470109302019 @default.
• W2147010930 countsByYear W21470109302020 @default.
• W2147010930 countsByYear W21470109302021 @default.
• W2147010930 countsByYear W21470109302022 @default.
• W2147010930 crossrefType "journal-article" @default.
• W2147010930 hasAuthorship W2147010930A5000225935 @default.
• W2147010930 hasAuthorship W2147010930A5007316380 @default.
• W2147010930 hasAuthorship W2147010930A5023112999 @default.
• W2147010930 hasAuthorship W2147010930A5034483419 @default.
• W2147010930 hasAuthorship W2147010930A5040190048 @default.
• W2147010930 hasAuthorship W2147010930A5051572998 @default.
• W2147010930 hasAuthorship W2147010930A5053482931 @default.
• W2147010930 hasAuthorship W2147010930A5064042438 @default.
• W2147010930 hasBestOaLocation W21470109301 @default.
• W2147010930 hasConcept C121608353 @default.
• W2147010930 hasConcept C126322002 @default.
• W2147010930 hasConcept C126838900 @default.
• W2147010930 hasConcept C126894567 @default.
• W2147010930 hasConcept C142724271 @default.
• W2147010930 hasConcept C143409427 @default.
• W2147010930 hasConcept C146957229 @default.
• W2147010930 hasConcept C150903083 @default.
• W2147010930 hasConcept C178790620 @default.
• W2147010930 hasConcept C185592680 @default.
• W2147010930 hasConcept C207001950 @default.
• W2147010930 hasConcept C26291073 @default.
• W2147010930 hasConcept C2776235491 @default.
• W2147010930 hasConcept C2777899217 @default.
• W2147010930 hasConcept C2779081379 @default.
• W2147010930 hasConcept C2780192828 @default.
• W2147010930 hasConcept C509974204 @default.
• W2147010930 hasConcept C540031477 @default.
• W2147010930 hasConcept C71924100 @default.
• W2147010930 hasConcept C7836513 @default.
• W2147010930 hasConcept C86803240 @default.
• W2147010930 hasConceptScore W2147010930C121608353 @default.
• W2147010930 hasConceptScore W2147010930C126322002 @default.
• W2147010930 hasConceptScore W2147010930C126838900 @default.

• next